3rd ESTRO Forum 2015 at low dose rates. Ppol maximum variation, for fields up to 10x10 cm 2 , was 0.8% while Pion showed a 0.4% maximum difference for the examined fields. The comparison between OF acquired with A26 and diode showed a mean difference of 0.7%; an exception is given by 1x1 cm 2 field, in which a 7.7% discrepancy between detectors was noticed. Profiles scanned by A26 were in agreement with diode (0.5 mm maximum penumbra variation for 2x2 cm 2 field). The comparison with profiles acquired by A1SL showed a 0.2 mm maximum penumbra difference for 3x3 cm 2 field. A26 Full Width at Half Maximum (FWHM) measurements showed a 0.4 mm (for 3x3 cm 2 field) and 0.2 mm (for 1x1 and 2x2 cm 2 fields) maximum difference compared to the results obtained by diode and A1SL respectively. As regards PDD, a good agreement was achieved between A26 and both diode and A1SL readings for 2x2 and 3x3 cm 2 fields (maximum difference 1.7%); for 1x1 cm 2 field (as shown in figure) , as depth increased, a not negligible difference (up to 10%) was observed between A26 and A1SL while the comparison with diode confirmed the good accordance shown previously.
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Conclusions: Not negligible differences between detectors were observed. Montecarlo correction factors for diode might explain the OF discrepancy with A26, while the A1SL bigger collecting volume could justify the variation observed in 1x1 cm 2 field PDD. Due to the lack of a gold standard detector for small field dosimetry, the previous measurements showed the reliability of A26 as detector for small fields. 6MV and 10 MV photon beams produced by a Varian Accelerator. Beam stability during irradiation was monitored with a PTW Semiflex Ionization Chamber (IC). W1 dose calibration for both energies was carried on at 10 cm depth in a 10x10cm 2 field, in two different condition of irradiated optical fiber length. Dose linearity was investigated at a dose rate of 300MU/min ranging from 4 to 1000 MU in 10x10 cm 2 field. Dose-rate dependence was also studied varying from 100 to 600 MU/min. The detector response depending on gantry orientation was tested in a 5x5cm 2 field, at 10° step angles from 340°to 40°. Relative output factors (ROF) were measured at 10cm depth for both energies with W1, PTW PinPoint IC and PTW microdiamond detector up to 0.4x.04cm 2 field. Results were also compared with Pinnacle 3 and RayStation TPSs calculated values. Results: Detector dose response showed a optimal linearity both for 6MV and 10MV, less than 0.5% up to 4MU and 1% for MU<4 but due to accelerator behavior. Regarding dose-rate dependence a standard deviation of 0.3% was observed among measurements performed in the range all dose-rates tested. Detector response showed a not negligible dependence on the length of fiber irradiated, observed both in calibration setup and during measurements at different gantry angle. Output factor measured with the 3 detectors showed a maximum difference of 1% for the 1x1cm 2 field. A poorer agreement was found for smaller field dimension. As expected, the same trend was observed comparing W1 detector measured ROF with calculated values, that is, a difference less than 0.5% up to 1x1cm 2 and worse beyond. Conclusions: Exradin W1 is a new detector that seems to introduce a minimum perturbation of the beam fluence. It is fast in data collection and easy to set up and manage. It show a good behavior in term of dose linearity and dose rate independence. MV is also reported to be dose-rate independent up to ultrahigh (≥ 10 6 Gy/s) dose-rates. The recent interest into using MV as a clinical dosimeter in radiotherapy is coupled with promising new radiotherapy techniques operating at these dose-rates, e.g. Flash irradiation and synchrotron radiation therapy. The purpose of this study is to characterize MV as a clinical dosimeter and to reveal its potential use in routine measurements at a radiotherapy department. Materials and Methods: When ionizing radiation interacts with a MV solution it produces radicals, which display a characteristic blue color. This occurs as visible light is strongly absorbed, with absorbance peaks at wavelengths (λ) of around 395 nm and 603 nm. Consequently, the absorbed dose by a MV solution is readily determined by measuring the optical density (absorbance) at those particular wavelengths with spectrophotometry. Hence, the absorbed dose (D) is given by: D = A λ · c λ where A λ is the absorbance (λ is 395 or 603 nm) and c λ is a constant which depends on the radiolytic yield (i.e. the amount of radicals created per absorbed joule), the density, and the molar extinction coefficient of the solution, as well as the path length of the light through the solution. The reproducibility of the MV dose measurements was assessed by irradiating samples of MV solution (introduced in optical cuvettes) with 1000 monitor units (MU) from a clinical electron beam (4 MeV at an Elekta Synergy) and repeating this process for 20 different solutions. The linearity response was checked by delivering 10 -10 000 MU to the solution, while the dose-rate dependence was investigated at normal clinical dose-rates by delivering 1 000 MU with varying doserate 25 -430 MU/min. Results: Our MV dose measurements show an acceptable level of reproducibility with a standard deviation for the 20 measurements of 1.8 % for both wavelengths. The dosimeter has a linear dose-response relationship between 500 -7 000 MU (≈ 5 -70 Gy), and is clinically usable (but not linear) down to 100 MU, see Figure 1 .
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Our results show a small dose-rate dependence of the MV response, specifically an increase of the response with higher dose-rate. This behavior is most likely due to the fading of the signal that occurs over time and starts to become a considerable factor for long irradiation sessions.
Conclusions:
The results of our study show that MV is useable as a clinical dosimeter within radiotherapy. Although its characteristics cannot rival those of ion-chambers or diodes at normal dose-rates, its reported dose-rate independence up to high dose-rates makes it of clinical interest. The characteristics of MV can make it a vital component in taking promising experimental radiotherapy techniques like high dose rate irradiation and synchrotron radiation therapy to clinical trials. and D 95% for all studied structures and two of the simulated scenarios with spatial delivery inaccuracies, whilst corresponding PTV DVHs are depicted in the included Figure  ( solid, dashed and dotted lines represent the scenarios of 0, 1 and 3 mm spatial errors in each axis, respectively).
